Thursday, April 27, 2017

Health Minister of Santa Fe explored new building sites at LIF

Minister Gonzalez visited LIF. He had a meeting with LIF’s Board of Directors and explored the new building sites for drugstore, and also research and development area.

    

      Health Minister of Santa Fe Province and LIF’s President visited LIF where he explored the new building area for research and development. This project includes a new area where LIF will be able to develop and produce four medicines to treat patients with tuberculosis disease.
     The project will require the investment of more than $21 million (ARG) of which $9.4 million (ARG) will be contributed by National Ministry of Innovation, Science and Technology through a FONARSEC* and the rest [$12.268.273,2.- (ARG)] will be contributed by LIF.
     Since 2014, new equipments and machines were incorporated for this project such as: FT NIR; weighing scales; HPLC; PH meter; polarimeter, titration equipment; two analytic shakers; film coating; blister-packed; mixer double cone; rotary tablet press machine and a metal detector for tablets. This required an investment of $7.915.970.- (ARG).

Objective
     The main objective of this project is that LIF will be able to develop and then produce four different medicines to treat patients with tuberculosis disease such as: Rifampicin + Isoniazid + Pyrazinamide (triple association); Ethambutol; Rifampin + Isoniazid (double association) and Isoniazid.

New building site for DIF.
     The new building site for storage was also explored by the group. This is a new site for DIF(1) area.
     After these activities LIF’s Board of Directors, General Manager, Trustee and Miguel Gonzalez had a meeting where they provided information about the production of metformin by the National Health Ministry. About that, LIF delivered in time 1.725.720 tablets of metformin of 10.100.100 tablets. This was the first delivery of six.
     Carlos Arques, Diego Bruno, Jorge Stettler and Guillermo Cleti (LIF’s Board of Directors); Guillermo Álvarez (LIF’s Trustee); Roberto Ganin (LIF’s General Manager) and Santiago Torales (Provincial Director of Quality and Sanitary Assessment) participated in these activities.

*FONARSEC: Fondo Argentino Sectorial. It is a financial instrument through which an institution can improve its capacity of production.
(1)DIF: Droguería Industrial Farmacéutica - Pharmaceutical Industry Drugstore.


José Natanson* visited LIF

The journalist and political scientist visited LIF. Meeting with LIF’s Board of Directors.



     The renowned Argentinian journalist José Natanson, Le Monde Diplomatique’s Director, visited LIF.
     Jorge Stettler, Diego Bruno, Guillermo Cleti and Carlos Arques (LIF’s Board of Directors); Guillermo Álvarez (Trustee) and Roberto Ganin (General Manager) welcomed Natanson and they shared information about the history, the present and the future of LIF.
     The public production of medicines for Santa Fe’s healthcare system and other different jurisdictions (such as the National Government); the production of orphan and critical drugs; the relationship with the technology and scientist world; the investment in building, equipment and staff training were some topics informed to the visitor.
     After meeting, the LIF’s facilities were visited by everybody.
 

*José Natanson
journalist and political scientist, he worked as writer and columnist at Página/12.

Usual collaborator for different national and Latin America media.
He led programs on radio and TV. He was editorial office’s boss in New Society newspaper.
He was PNUD advisor. His last book is called: "La nueva izquierda. Triunfos y derrotas de los gobiernos de Argentina. Venezuela, Chile, Uruguay, Bolivia, Brasil y Ecuador", Debate-Random House Mondadori (2007).

Tuesday, February 21, 2017

LIF and CONICET* will work different activities together

Carlos Arques, Diego Bruno and Guillermo Cleti (LIF’s Directors), received Ulises Sedran (CONICET’s Director) and Melisa Bertero (Member of the Investigation Institute of Catalysis and Petrochemistry - CONICET).
 
     In this meeting, they talked about the development and validation of technical analysis for new drugs.
     Both institutions will sign an agreement to progress in these activities.
     CONICET will contribute with equipment, facilities, experience and staff while LIF will contribute with raw material, chemical elements and staff.
     Guillermo Álvarez (LIF’s Trustee) and Roberto Ganin (General Manager) also participated in the meeting.
     Since 2009, LIF and CONICET are members of “Provincial Network for Production, Research and Pharmaceutical Technology”. This network has as main objectives: to coordinate the public production of medicines and to promote innovation and research.

*CONICET: Consejo Nacional de Investigaciones Científicas y Técnicas - National Committee of Scientific and Technical Research.

Meeting at ANLAP

Diego Bruno and Jorge Stettler, participated in a meeting at ANLAP*. They were received by Alfonso Sánchez de León (ANLAP’s President).
  
     In this meeting LIF’s Directors could meet the new ANLAP’s authorities and informed them of the different activities and projects that LIF has been making in the last couple of years such as production of different medicines for National Health Ministry and production of opioids for INC(1).
     María Fernanda Pesado (LEM’s Director) and Martín Grigioni (Member of Health Secretary of Rosario city) also participated in the meeting.
     Sánchez de León informed that ANLAP’s budget for this year will be of $85.000.000 (ARG). Then, he expressed that in 2017 the National Health Ministry will finish the delivery of medicines through CUM(2) and this activity will be made by different provinces.
     Finally, he said that March might be the time for the first meeting of the ANLAP’s Executive Committee (LIF is one of the members of this Committee).

(*) ANLAP: Agencia Nacional de Laboratorios Públicos - National Agency of Public Laboratories.
(1)INC: Instituto Nacional del Cáncer - National Cancer Institute.
(2) CUM: cobertura universal de medicamentos - Medicines Universal Coverage.

Tuesday, December 6, 2016

Meeting at the Health Ministry of Mendoza Province

LIF’s and LEM’s members participated in a meeting with Health Ministry’s civil servants from Mendoza province. They progressed in reaching an agreement.

     LIF’s Directors: Carlos Arques, Diego Bruno and César Daniel Salomón had a meeting with Oscar Zagas, Health Sub Secretary.
     In this meeting also participated Cecilia Orueta, Pharmacy Director; Viviana Yuvel, Administration Director; Marité Miranda y Andrea Silva, Pharmacology Direction’s members; Cecilia Cejas, Planning Department Director and Marcelo Rujana, LEM’s Administration.
     They talked about an agreement of mutual collaboration and assistance in the production of medicines between Mendoza and Santa Fe.
     Mendoza’s Health Ministry had a project to produce medicines through a public laboratory (LAPROMED*). This laboratory might start working in 2017. LIF and LEM(+) could an important participation such as advisors.
     Finally, LIF and LEM members offered their medicine portfolio to provide in public healthcare centers of Mendoza.

(+)LEM: Laboratorio de Especialidades Medicinales de la Municipalidad de Rosario - Medicines Specialties Laboratory of Rosario’s Municipality.
*LAPROMED: public laboratory of medicines from Mendoza province.

New Administration Area’s opening ceremony



     Carlos Fascendini (Santa Fe’s Vice Governor) and Miguel González (Santa Fe’s Health Minister) participated at the open ceremony of the new building of LIF’s Administration Area.
     The meeting took place at the LIF’s headquarters where Eduardo Matozo (Santa Fe’s Science and Technology Minister); LIF’s Board of Directors: Carlos Arques, Guillermo Cleti, Diego Bruno and  Daniel Salomón; Roberto Ganin (LIF’s General Manager); Carlos Minatti (LIF’s Trustee) also attended.
     This first stage started in 2014 and it required $10 million (ARG). The building has 400 square meter and twenty two job positions.
     The second stage will start in October when LIF will request a new bidding to build the top floor sector where there will be more offices.
 
Budget of Santa Fe province and National Government.
     For this building LIF invested $10 millions (ARG) of which $3 millions were contributed by National Government through an agreement between LIF and National Institute of Cancer. Due to this, LIF researched, produced and delivered methadone and morphine tablets in different hospitals.
     Methadone and morphine are drugs for pain treatment in patients with active, progressive and advanced diseases.

LIF participated in the IV CLAMME

     LIF participated in the IV “Congreso Latinoamericano de Microbiologìa de Medicamentos y Cosméticos” (CLAMME). 
     It took place in Rosario.
Biochemist Lisandro Zili gave a lecture on Public Production of Medicines.
     First, Zili presented the idea that The State must act as guarantee to the access to health; second, he also claimed that citizens must be granted medicines as a social right; third he stated that Management must be transparent. Last, technological innovations and new challenges were also some topics explained by Zili.
     Finally, he finished the lecture speaking about quality control and microbiology techniques.